AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2022
May 17, 2022
34129_dirs_2022-05-17_32f0bcde-4442-40c9-8e04-c91eda39bafd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2022-05-14
Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-14 | Common Stock | M | 5000 | — | Acquired | 116090 | Direct |
| 2022-05-14 | Common Stock | F | 1666 | $4.16 | Disposed | 114424 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-14 | Restricted Stock Unit | $0.0 | M | 5000 | Disposed | Common Stock (5000.0) | Direct |
Footnotes
F1: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which vested on May 14, 2022. Restricted stock units convert into the Company's common stock on a one-for-one basis
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18